Latest News

Instem Awarded EMA Research Grant

Instem Secures Portion of €2.5m Grant as Member of Research Consortium Investigating the Mutagenicity of N-nitrosamines

PHILADELPHIA, PA – (BUSINESS WIRE) – May 10, 2022 - Instem, a leading provider of IT solutions and services to the global life sciences market, announced today that it has been awarded a European Medicines Agency (EMA) grant as part of an EMA-funded research project to better understand the mutagenicity of N-nitrosamines.


Instem Expands In Silico Toxicology Service To Meet Growing Demand

November 22, 2021 - Newly Added Services to Support Latest Regulatory Guidance and Growing Demand for Alternative Testing Methods


Instem Acquires PDS Life Sciences to Help Clients Bring Life Enhancing Products to Market Faster and More Efficiently

September 1, 2021 - Acquisition of PDS Life Sciences Consolidates Non-Clinical Market; Further Extends Instem’s Leadership in Study Management and Regulatory SEND Submission Support


Instem to Release Next Edition of its Leading Computational Toxicology Software Suite

July 29, 2021 - Powerful New In Silico Models and First-to-Market Software Capabilities to Deliver Further Efficiencies and Increased Regulatory Compliance


Instem Acquires Market Leader d-wise to Further Accelerate Life Science Development

March 22, 2021 - Instem’s Acquisition of Leading Clinical Trial Technology and Consulting Provider d-wise Represents Substantial Advancement of its Mission


View all news

 

Events

ICEM 2022 Annual Meeting

August 27 - September 1, 2022

Ottawa, Canada


Presentation:
'ICH M7 expert review procedures and assessment of specific chemical classes', Kevin Cross

Visit Conference Site


RAPS US Convergence 2022

September, 11 - 13, 2022

Phoenix Convention Center, Phoenix, Arizona, Booth #823

Visit Conference Site


SPS Annual Meeting 2022

September, 11 - 14, 2022

Palais des congrès de Montréal, Montreal, Booth #803

Visit Conference Site

View all events